Filter posts

Fall Preview: Business Development Events

Now that the Business Forum and International Convention are behind us, our Business Development department …

State of the Industry - From BIO Investor Forum 2010

Here is our slide deck from the 9th annual BIO Investor Forum in San Francisco: …

The booming H1N1 vaccine market

The vaccine market is booming – and biotech companies are just one of the beneficiaries.  …

Perspectives on today's IPO candidates

Some speculation is coming back into the sector but most movement in public markets is …

Panelists make it personal

Panelists in the “Making it Personal” session discussed the clinical utility, comparative effectiveness implications and …

The race against pandemic flu

Panelists at this morning’s Therapeutic Workshop, “Predicting a Frontrunner in the Race Against Pandemic Flu” …

Positive results for Logical Therapeutics’ LT-NS001 vs. Naproxen clinical study

Logical Therapeutics, Inc. announced positive results of a Phase I/II clinical trial evaluating the gastrointestinal …

Endocyte awarded patent for vitamin receptor binding drug delivery conjugates

Endocyte, Inc. has been awarded a patent from the United States Patent and Trademark Office …

Oncolytics® Biotech Inc. issues 33rd U.S. patent

Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) has been granted its 33rd U.S. Patent, No. …

Biotech and the flu pandemic

Biotechnology researchers are working to create new vaccination options to help stop the next big …